Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 1
1967 1
1969 1
1972 1
1974 4
1975 1
1977 3
1979 2
1986 2
1987 3
1988 1
1990 1
1991 2
1992 1
1996 2
2000 2
2002 1
2003 1
2005 2
2006 2
2007 3
2008 3
2009 4
2010 5
2011 3
2012 2
2013 5
2014 5
2015 6
2016 7
2017 10
2018 3
2019 6
2020 11
2021 6
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.
Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Bruix J, et al. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Lancet. 2017. PMID: 27932229 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. Among authors: le berre ma. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
Smith MR, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Mohamed AF, Odom D, Bartsch J, Snapir A, Sarapohja T, Fizazi K. Smith MR, et al. Among authors: le berre ma. Eur J Cancer. 2021 Sep;154:138-146. doi: 10.1016/j.ejca.2021.06.010. Epub 2021 Jul 14. Eur J Cancer. 2021. PMID: 34273811 Free article. Clinical Trial.
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial.
Finn RS, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Gerolami R, Caparello C, Cabrera R, Chang C, Sun W, LeBerre MA, Baumhauer A, Meinhardt G, Bruix J. Finn RS, et al. J Hepatol. 2018 Aug;69(2):353-358. doi: 10.1016/j.jhep.2018.04.010. Epub 2018 Apr 26. J Hepatol. 2018. PMID: 29704513 Clinical Trial.
Scaling laws in turbulence.
Josserand C, Le Berre M, Pomeau Y. Josserand C, et al. Among authors: le berre m. Chaos. 2020 Jul;30(7):073137. doi: 10.1063/1.5144147. Chaos. 2020. PMID: 32752609
Caring for older cancer patients: A scoping review.
Bagayogo F, Le Berre M, Ruchon C, Denis JL, Lamothe L, Vedel I, Lapointe L. Bagayogo F, et al. Among authors: le berre m. Health Policy. 2020 Sep;124(9):1008-1016. doi: 10.1016/j.healthpol.2020.05.002. Epub 2020 May 29. Health Policy. 2020. PMID: 32532568 Review.
Exploring the function of cell shape and size during mitosis.
Cadart C, Zlotek-Zlotkiewicz E, Le Berre M, Piel M, Matthews HK. Cadart C, et al. Among authors: le berre m. Dev Cell. 2014 Apr 28;29(2):159-69. doi: 10.1016/j.devcel.2014.04.009. Dev Cell. 2014. PMID: 24780736 Free article. Review.
112 results